Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Chabannon C, Le Corroller AG, Viret F, Eillen C, Faucher C, Moatti JP, Viens P, Vey N, Braud AC, Novakovitch G, Ladaique P, Stoppa AM, Camerlo J, Genre D, Maraninchi D, Blaise D. Chabannon C, et al. Among authors: maraninchi d. Leukemia. 2003 Apr;17(4):811-3. doi: 10.1038/sj.leu.2402867. Leukemia. 2003. PMID: 12682645 No abstract available.
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
Oddou S, Vey N, Viens P, Bardou VJ, Faucher C, Stoppa AM, Chabannon C, Camerlo J, Bouabdallah R, Gastaut JA, Maraninchi D, Blaise D. Oddou S, et al. Among authors: maraninchi d. Leuk Lymphoma. 1998 Sep;31(1-2):187-94. doi: 10.3109/10428199809057598. Leuk Lymphoma. 1998. PMID: 9720728 Clinical Trial.
Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study.
Reiffers J, Stoppa AM, Attal M, Michallet M, Marit G, Blaise D, Huguet F, Corront B, Cony-Makhoul P, Gastaut JA, Laurent G, Molina L, Broustet A, Maraninchi D, Pris J, Hollard D, Faberes C. Reiffers J, et al. Among authors: maraninchi d. Leukemia. 1996 Dec;10(12):1874-82. Leukemia. 1996. PMID: 8946925 Clinical Trial.
Interleukin 2 in the treatment of acute leukemia.
Blaise D, Maraninchi D. Blaise D, et al. Among authors: maraninchi d. Leuk Res. 1998 Dec;22(12):1165-70. doi: 10.1016/s0145-2126(98)00115-5. Leuk Res. 1998. PMID: 9922080 Review. No abstract available.
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients.
Bouabdallah R, Stoppa AM, Rossi JF, Lepeu G, Coso D, Xerri L, Ladaique P, Chabannon C, Blaise D, Bardou VJ, Alzieu C, Gastaut JA, Maraninchi D. Bouabdallah R, et al. Among authors: maraninchi d. Leukemia. 1999 Jun;13(6):950-6. doi: 10.1038/sj.leu.2401444. Leukemia. 1999. PMID: 10360385
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy.
Bagnis C, Chabannon C, Gravis G, Imbert AM, Maroc C, Bardin F, Ladaique P, Viret F, Genre D, Faucher C, Stoppa AM, Vey N, Blaise D, Maraninchi D, Viens P, Mannoni P. Bagnis C, et al. Among authors: maraninchi d. Exp Hematol. 2002 Feb;30(2):108-15. doi: 10.1016/s0301-472x(01)00773-1. Exp Hematol. 2002. PMID: 11823045 Free article.
High-dose chemotherapy in advanced breast cancer.
Viens P, Maraninchi D. Viens P, et al. Among authors: maraninchi d. Crit Rev Oncol Hematol. 2002 Feb;41(2):141-9. doi: 10.1016/s1040-8428(01)00151-2. Crit Rev Oncol Hematol. 2002. PMID: 11856590 Review.
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease.
Fleury J, Legros M, Colombat P, Cure H, Travade P, Tortochaux J, Dionet C, Chollet P, Linassier C, Lamagnere JP, Blaise D, Viens P, Maraninchi D, Plagne R. Fleury J, et al. Among authors: maraninchi d. Leuk Lymphoma. 1996 Jan;20(3-4):259-66. doi: 10.3109/10428199609051616. Leuk Lymphoma. 1996. PMID: 8624465 Clinical Trial.
314 results